Study plagiarizes so many other papers, retraction notice can’t list them all

In a new retraction notice, the Journal of Controlled Release is living up to its name.

The editor-in-chief has retracted a study that plagiarized “a large number” of papers, but only three are listed in the notice. Here’s the notice for “In situ-forming hydrogels for sustained ophthalmic drug delivery,” by Basavaraj K. Nanjawade, F.V. Manvi, and A.S. Manjappa, three researchers at India’s KLES’s College of Pharmacy, JN Medical College Campus, Karnataka:

Statins without prescription website paper retracted after company says it requires scripts, threatens suit

The authors of a paper on websites that sell cholesterol-lowering statin medications without prescriptions have retracted it. The move followed the threat of a lawsuit against the journal by a company included in the study that says it never dispenses sans a script.

Here’s the notice:

JPET peeves: Paper withdrawn after drug company won’t disclose chemical structure

A group of researchers at the drug company ChemoCentryx is withdrawing a 2012 paper in the Journal of Pharmacology and Experimental Therapeutics over failure to appropriately identify the molecule they describe in the article.

The withdrawal notice tells the story: